These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21727995)

  • 1. Serum levels of fatty acid synthase in colorectal cancer patients are associated with tumor stage.
    Notarnicola M; Tutino V; Calvani M; Lorusso D; Guerra V; Caruso MG
    J Gastrointest Cancer; 2012 Sep; 43(3):508-11. PubMed ID: 21727995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid synthase (FASN) levels in serum of colorectal cancer patients: correlation with clinical outcomes.
    Long QQ; Yi YX; Qiu J; Xu CJ; Huang PL
    Tumour Biol; 2014 Apr; 35(4):3855-9. PubMed ID: 24430360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of annexin A5 in serum and tumor tissue of patients with colon cancer and its clinical significance.
    Sun CB; Zhao AY; Ji S; Han XQ; Sun ZC; Wang MC; Zheng FC
    World J Gastroenterol; 2017 Oct; 23(39):7168-7173. PubMed ID: 29093625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Level of Fatty Acid Synthase Enzyme Predicts Lower Rate of Completing Debulking Surgery in Epithelial Ovarian Cancer.
    Winarno GNA; Hidayat Y; Soetopo S; Krisnadi SR; Tobing MDL; Rauf S
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2859-2863. PubMed ID: 33112541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokine levels in patients with colorectal cancers according to tumor stages and VEGF gene polymorphism.
    Bayhan Z; Simşek T; Ergül E; Utkan NZ; Canturk NZ; Cekmen M
    Hepatogastroenterology; 2014 Oct; 61(135):1889-94. PubMed ID: 25713884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reevaluation of serum p53 antibody as a tumor marker in colorectal cancer patients.
    Ochiai H; Ohishi T; Osumi K; Tokuyama J; Urakami H; Seki S; Shimada A; Matsui A; Isobe Y; Murata Y; Endo T; Ishii Y; Hasegawa H; Matsumoto S; Kitagawa Y
    Surg Today; 2012 Jan; 42(2):164-8. PubMed ID: 22075664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients.
    Wang Y; Kuhajda FP; Li JN; Pizer ES; Han WF; Sokoll LJ; Chan DW
    Cancer Lett; 2001 Jun; 167(1):99-104. PubMed ID: 11323104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of serum concentrations of intercellular adhesion molecule-1 in patients with colorectal cancer.
    Kang X; Wang F; Xie JD; Cao J; Xian PZ
    World J Gastroenterol; 2005 Jul; 11(27):4250-3. PubMed ID: 16015700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients.
    Pietrzyk Ł; Wdowiak P
    Adv Med Sci; 2019 Sep; 64(2):402-408. PubMed ID: 31352222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.
    Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D
    Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
    Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
    Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum placenta growth factor level as a new marker for stage II or III colorectal cancer patients.
    Kemık O; Sarbay Kemık A; Sümer A; Purısa S; Tükenmez B; Tüzün S
    Turk J Gastroenterol; 2012 Apr; 23(2):104-9. PubMed ID: 22706737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.
    Ben QW; Zhao Z; Ge SF; Zhou J; Yuan F; Yuan YZ
    Int J Oncol; 2009 Mar; 34(3):821-8. PubMed ID: 19212687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an enzyme-linked immunosorbent assay for detection of CDCP1 shed from the cell surface and present in colorectal cancer serum specimens.
    Chen Y; Harrington BS; Lau KCN; Burke LJ; He Y; Iconomou M; Palmer JS; Meade B; Lumley JW; Hooper JD
    J Pharm Biomed Anal; 2017 May; 139():65-72. PubMed ID: 28279929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma.
    Fernandes LC; Kim SB; Matos D
    World J Gastroenterol; 2005 Feb; 11(5):645-8. PubMed ID: 15655814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.
    Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
    Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
    Han D; Wei Y; Wang X; Wang G; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
    Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
    Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.